StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJul 17, 2026, 08:51 AM

VivoSim Labs Secures $4.0M Private Placement

AI Summary

VivoSim Labs, Inc. entered into a Securities Purchase Agreement with an institutional investor for a private placement, raising approximately $4.0 million. The company will issue pre-funded warrants and common warrants to purchase up to 4,705,883 shares of common stock each, at a combined purchase price of $0.85 per share. Proceeds will be used for working capital and general corporate purposes. Additionally, existing warrants issued to Armistice Capital will be amended to reduce their exercise price to $0.85 per share, subject to stockholder approval.

Key Highlights

  • VivoSim Labs secured approximately $4.0 million in gross proceeds from a private placement.
  • The company will issue pre-funded warrants and common warrants for 4,705,883 shares each.
  • The combined purchase price for the warrants is $0.85 per share.
  • Proceeds from the private placement will be used for working capital and general corporate purposes.
  • A.G.P./Alliance Global Partners will receive a 6.50% cash fee as the placement agent.
  • Existing Armistice Warrants for 520,833 shares will have their exercise price reduced to $0.85 per share, subject to stockholder approval.
  • The closing of the private placement is expected on or about July 17, 2026.